Shares of Novadaq Technologies Inc. (NASDAQ:NVDQ) (TSE:NDQ) have been assigned a consensus rating of “Hold” from the fourteen brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating and one has issued a buy rating on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $12.00.

Several equities analysts recently issued reports on the stock. Royal Bank Of Canada reissued a “hold” rating and set a $11.75 price target on shares of Novadaq Technologies in a report on Friday, September 1st. Zacks Investment Research raised shares of Novadaq Technologies from a “sell” rating to a “hold” rating in a report on Friday, August 18th. Canaccord Genuity reissued a “hold” rating and set a $11.75 price target on shares of Novadaq Technologies in a report on Friday, September 1st. Northland Securities reissued a “hold” rating and set a $11.75 price target on shares of Novadaq Technologies in a report on Monday, August 14th. Finally, BidaskClub raised shares of Novadaq Technologies from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd.

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Broadfin Capital LLC bought a new position in shares of Novadaq Technologies in the second quarter worth about $11,720,000. CNH Partners LLC bought a new position in shares of Novadaq Technologies in the second quarter worth about $7,340,000. State Street Corp raised its stake in shares of Novadaq Technologies by 42.7% in the second quarter. State Street Corp now owns 38,678 shares of the medical research company’s stock worth $453,000 after acquiring an additional 11,578 shares during the last quarter. Janus Henderson Group PLC bought a new position in shares of Novadaq Technologies in the second quarter worth about $32,663,000. Finally, Goldman Sachs Group Inc. raised its stake in shares of Novadaq Technologies by 2,035.3% in the second quarter. Goldman Sachs Group Inc. now owns 1,814,404 shares of the medical research company’s stock worth $21,265,000 after acquiring an additional 1,729,431 shares during the last quarter. 75.38% of the stock is owned by institutional investors.

Novadaq Technologies (NVDQ) opened at $11.75 on Thursday. Novadaq Technologies has a 1-year low of $5.84 and a 1-year high of $12.74. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.49 and a quick ratio of 3.30.

WARNING: This news story was published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/novadaq-technologies-inc-nvdq-given-average-recommendation-of-hold-by-brokerages/1733931.html.

About Novadaq Technologies

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Analyst Recommendations for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.